Athersys
ATHX
$0.01350
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Athersys (ATHX) - Total debt
Total debt on the balance sheet as of September 2023 : $18.57 M
According to Athersys's latest financial reports the company's total debt is $18.57 M. A company’s total debt is the sum of all current and non-current debts.
Athersys - Total debt on balance sheet (from 2006 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $8.68 M | -11.07% |
| 2021-12-31 | $9.76 M | |
| 2016-12-31 | $1 M | 428.42% |
| 2015-12-31 | $0.19 M | 3.83% |
| 2014-12-31 | $0.18 M | 3.98% |
| 2013-12-31 | $0.17 M | 4.14% |
| 2012-12-31 | $0.16 M | |
| 2008-12-31 | $N/A | -100% |
| 2007-12-31 | $1.78 M | |
| 2003-12-31 | $0.57 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 157,794.17% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 381,258.67% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 347,711.81% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | 109,536.11% | 🇫🇷 France |
 Merck MRK | $35.05 B | 188,601.08% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $41.46 B | 223,100.73% | 🇺🇸 USA |
 Moderna
MRNA | $1.24 B | 6,591.07% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |